Instrument Inactif

Communiqués Nanomix Corporation

Actions

NNMX

US63008H2013

Equipement et technologie médicale avancés

Communiqués

13/04/23	Nanomix Announces Equity Investment from Senior Executive of Woodley Equipment Company, Ltd. at a Premium to Market	GL
07/04/23	NANOMIX CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	AQ
10/03/23	NANOMIX CORP : Regulation FD Disclosure (form 8-K)	AQ
25/01/23	NANOMIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
25/01/23	Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer	GL
25/01/23	Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer	GL
29/11/22	Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy	GL
29/11/22	Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy	GL
10/11/22	NANOMIX CORP : Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
09/11/22	Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.	GL
09/11/22	Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.	AQ
04/11/22	Nanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group Limited	GL
04/11/22	Nanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group Limited	AQ
20/10/22	Nanomix Enters into Distribution Agreement for the eLab System with Diaclinic SpA in Chile	GL
20/10/22	Nanomix Enters into Distribution Agreement for the eLab System with Diaclinic SpA in Chile	AQ
12/09/22	Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with IPS Genomix s.a.l. in the Middle East	GL
12/09/22	Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with IPS Genomix s.a.l. in the Middle East	AQ
09/09/22	NANOMIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
02/09/22	Nanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies	GL
02/09/22	Nanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies	GL
31/08/22	Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D., to the Board of Directors	AQ
31/08/22	Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D., to the Board of Directors	GL
23/08/22	Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with BIOASIA PTE LTD in Singapore	GL
23/08/22	Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with BIOASIA PTE LTD in Singapore	GL
18/08/22	Nanomix Announces ISO 13485:2016 Certification for its New Facility in San Leandro, CA	GL